We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Increased Triglyceride Content Associated with Plasma Lipoprotein Lipase

By LabMedica International staff writers
Posted on 15 Feb 2017
Print article
Image: Small, dense LDL particles have less anti-oxidants and are associated with a much higher risk of atherosclerosis. Large, buoyant LDL particles are rich in anti-oxidants and present a much lower risk of oxidizing than the small, dense LDLs (Photo courtesy of Dr. David Jockers).
Image: Small, dense LDL particles have less anti-oxidants and are associated with a much higher risk of atherosclerosis. Large, buoyant LDL particles are rich in anti-oxidants and present a much lower risk of oxidizing than the small, dense LDLs (Photo courtesy of Dr. David Jockers).
Non-fasting plasma triglyceride (TG) reflect a higher risk for cardiovascular disease (CVD) than TG in the fasting plasma and this the postprandial increase of TG is the most common form of hyperlipidemia which is associated with increased remnant lipoproteins (RLP) as a risk factor for CVD.

It has been reported that the fasting TG concentration was not an independent cardiovascular risk factor, while RLP-cholesterol (RLP-C) was an independent risk factor in the fasting plasma in women. Therefore, it is necessary to investigate the difference between fasting and postprandial TG and RLP.

An international team of scientists working with those at Gunma University Graduate School of Medicine recruited 54 volunteers (30 males and 24 females, aged 28 to 63 years) who were without evidence of CVD, diabetes or other chronic disease for the oral fat load test. TG and RLP-TG together with other lipids, lipoproteins and lipoprotein lipase (LPL) in both fasting and postprandial plasma were determined in generally healthy volunteers and in patients with coronary artery disease (CAD) after consuming a fat load or a more typical moderate meal.

RLP-C and RLP-TG were determined using an immunoseparation method and Small Dense Low Density Lipoprotein cholesterol (LDL-C) was also determined by a commercial kit. The team found that RLP-TG/TG ratio (concentration) and RLP-TG/RLP-C ratio (particle size) were significantly increased in the postprandial plasma of both healthy controls and CAD patients compared with those in fasting plasma. LPL/RLP-TG ratio demonstrated the interaction correlation between RLP concentration and LPL activity The increased RLP-TG after fat consumption contributed to approximately 90% of the increased plasma TG, while approximately 60% after a typical meal. Plasma LPL in postprandial plasma was not significantly altered after either type of meal.

The authors concluded that non-fasting TG concentrations to be stronger predictor for the risk of CVD than fasting TG, because of the higher concentration of a larger sized RLP particles expressed as higher RLP-TG along with a small amount of LPL in the postprandial plasma compared to the fasting plasma. Therefore, non-fasting TG measurements performed 3 to 6 hours after food intake may be able to take the place of the direct measurement of RLP-TG for the assessment of cardiovascular disease risk. The study was published in the February 2017 issue of the journal Clinica Chimica Acta.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.